Eligibility Criteria:  Have an HIV-1 infection  a) Currently take a long-acting injectable therapy for HIV supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or  b) Currently take a long-acting injectable therapy for HIV prescribed by their provider, not in conjunction with a ViiV-sponsored clinical trial, or  c) No longer taking long-acting injectable therapy for HIV, but previously received three or more injections of long-acting injectable therapy, either:  Supplied by ViiV as part of a ViiV-sponsored, long-acting injectables therapy trial (LATTE-2, ATLAS-2M, CUSTOMIZE, POLAR, FLAIR, or SOLAR), or Prescribed by their provider, unrelated to a ViiV-sponsored clinical trial. Age 18 or above Have no known acute medical problem requiring immediate inpatient treatment Able to read and write in English Able and willing to provide online informed consent and to complete the online profile Not currently enrolled in another clinical trial in which the participant is receiving a long-acting injectable therapy for HIV.  Participants who meet the eligibility criteria but are still receiving ViiV-supplied drug may enroll in the registry, but will not begin the online questionnaire until they are rolled off of ViiV-supplied long-acting injectable therapy.